NuGen Medical Devices Inc.
NGMD.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.24% | 74.11% | 57.54% | 79.07% | 44.44% |
| Total Depreciation and Amortization | 4.92% | -1.38% | -7.08% | -10.37% | -7.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,457.25% | -165.22% | -176.66% | -214.76% | -91.00% |
| Change in Net Operating Assets | 23.81% | -200.07% | -153.52% | -205.92% | 61.72% |
| Cash from Operations | 25.10% | -64.85% | -58.53% | 16.93% | 31.49% |
| Capital Expenditure | -2,843.24% | -4,463.64% | -1,977.27% | -236.36% | -236.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.67% | 8.33% | 98.43% | 97.63% | 96.81% |
| Cash from Investing | -2,444.19% | -2,885.29% | -14.60% | 79.30% | 78.39% |
| Total Debt Issued | -- | -100.00% | 51.98% | 51.98% | 51.98% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 99.19% | 96.81% |
| Issuance of Common Stock | -95.10% | -43.92% | -74.92% | -91.58% | -84.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.49% | -95.84% | 391.99% | 88.95% | 55.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.92% | -164.22% | 593.56% | 13,857.64% | 1,759.38% |